Bioassay guided fractionation of the ethanolic extract of Asphodelus microcarpus Salzm.et Vivi (Asphodelaceae) resulted in the isolation of one new metabolite, 1,6-dimethoxy-3-methyl-2-naphthoic acid (1) as well as nine known compounds: asphodelin (2), chrysophanol (3), 8-methoxychrysophanol (4), emodin (5), 2-acetyl-1,8-dimethoxy-3-methylnaphthalene (6), 10-(chrysophanol-7′-yl)-10-hydroxychrysophanol-9-anthrone (7), aloesaponol-III-8-methyl ether (8), ramosin (9) and aestivin (10). The compounds were identified by 1D and 2D NMR and HRESIMS. Compounds 3, 6 and 10 were isolated for the first time from this species. Compounds 3 and 4 showed moderate to weak antileishmanial activity with IC 50 values of 14.3 and 35.1 µg/mL, respectively. Compound 4 exhibited moderate antifungal activity against Cryptococcus neoformans with an IC 50 value of 15.0 µg/mL, while compounds 5, 7 and 10 showed good to potent activity against methicillin resistant Staphylococcus aureus (MRSA) with IC 50 values of 6.6, 9.4 µg/mL and 1.4 µg/mL respectively. Compounds 5, 8 and 9 displayed good activity against S. aureus with IC 50 values of 3.2, 7.3 and 8.5 µg/mL, respectively. Compounds 7 and 9 exhibited a potent cytotoxic activity against leukemia LH60 and K562 cell lines. Compound 10 showed potent antimalarial activities against both chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum with IC 50 values in the range of 0.8-0.7 µg/mL without showing any cytotoxicity to mammalian cells.
The ethanolic extract of A. microcarpus yielded ten compounds ( Figure 1 ). 1, 6-Dimethoxy-3-methyl-2-naphthoic acid (1) was obtained as a yellowish white amorphous powder. HREIMS gave an [M-H]ion at m/z 245.08816 (calcd. for C 14 H 13 O 4 , 245.08137), consistent with the molecular formula of C 14 H 14 O 4 with 8 degrees of unsaturation. The 13 C NMR, DEPT, and HMQC of 1 displayed 14 carbon signals, including one methyl group at δ 18.9(C-3), two methoxy groups at δ 63.1 (C-1) and 55.9 (C-6), 4 methines at δ 124.0 (C-4), 120.0 (C-5), 105.9 (C-7), and 127.1 (C-8) and 6 quaternary carbons at δ 152.0(C-1), 129.5 (C-2), 132.0 (C-3), 155.6 (C-6), 117.4 (C-9), and 136.4 (C-10) as well as a carbonyl carbon at δ 169.4 (on carbon C-2). The 1 H NMR spectrum displayed a methyl singlet at δ 2.32 (3H, s, H-3), two methoxy singlets at δ 3.75 (3H, s, H-1) and 3.91 (3H, s, H-6), four aromatic protons at δ 7.46 (1H, s, H-4), 7.38 (1H, d, H-5, J=2 Hz ), 6.93 (1H, dd, H-7, J =2.1, 6.8 Hz), and 7.39 (1H, d, H-8, J =6.8 Hz). The HMBC spectrum exhibited cross-peaks from H-4 to C-5, C-9, C-2 and the C-3 methyl carbon, from the C-3 methyl protons to C-2, C-4 and C-3, from H-5 to C-4, C-6 and C-9, from H-7 to C-6, C-5 and C-9, and from H-8 to C-6 and C-10. Accordingly compound 1 was 1, 6-dimethoxy-3methyl-2-naphthoic acid.
Compounds 2-10 were identified by 1 H NMR, 13 [8] , 10-(chrysophanol-7′-yl)-10-hydroxychrysophanol-9-anthrone 7 [9] , aloesaponol III-8-methyl ether 8 [10] , ramosin 9 [6] and aestivin 10 [9] . [see Supplementary Data] Table 2 : Inhibitory effects of 7 and 9 on the growth of human leukemia cells in vitro (48 h drug exposure for HL60 and K562 cells). Experiments were carried out in triplicate.
Figure 2:
The concentration-dependent effects of Compounds 7 and 9 on the growths of acute leukemia HL60 (Cells were treated with compounds for 48 h and then cell numbers were determined by the trypan blue exclusion test. Results shown are mean ± SD (bars) of triplicate experiments. Compounds 1-10 were evaluated for their antimicrobial, antimalarial, antileishmanial and antileukemic activities. Compound 6 exhibited moderate antifungal activity against Cryptococcus neoformans with an IC 50 value of 15.0 µg/mL. Compounds 5, 7, and 10 showed good to potent activity against MRSA with IC 50 values of 6.6, 9.4, and 1.4 µg/mL respectively, while Compounds 5, 8 and 9 showed good activity against S. aureus with IC 50 values of 3.2, 7.3 and 8.5 µg/mL, respectively. Compounds 3 and 4 showed antileishmanial activity with IC 50 values of 14.3 and 35.1 µg/mL, respectively indicating a decrease in activity by methylation of the 8-hydroxyl group. Also, compounds 7 and 9 displayed potent cytotoxic activity against leukemia HL60 and K562 cell lines (table  2) . Compound 10 showed potent antimalarial activities against both chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum with IC 50 values in the range of 0.8-0.7 µg/mL without showing any cytotoxicity to the mammalian cells.
Experimental
General: NMR spectra were recorded on a Bruker Avance DRX-500 instrument at 500 ( 1 H) and 125 MHz ( 13 C), and a Varian Mercury 400 MHz spectrometer at 400 ( 1 H) and 100 MHz ( 13 C). The HRESIMS spectra were measured using a Bruker Bioapex-FTMS with electrospray ionization (ESI). Column chromatographic separation was performed on silica gel 60 (0.04-0.063 mm) and Sephadex LH-20 (0.25-0.1 mm, Merck). TLC was performed on precoated TLC plates with silica gel 60 F254 (0.2 mm, Merck). Semipreparative HPLC (Waters Delta Prep 4000) was performed using Luna® RP-18(5 µg, 250, 10mm).
Plant Material:
The tubers of Asphodelus microcarpus were collected from an area 70 Km West of Marsa Matrouh, Egypt, during March, 2011. The plant was authenticated by Dr. Ibrahim El-Garf, Professor of Plant Taxonomy, Cairo Univ., Egypt. A voucher specimen (AM 21) has been deposited in the Pharmacognosy Department, Faculty of Pharmacy, Al-Azhar Univ., Cairo, Egypt.
Extraction and isolation:
The air-dried powdered plant material (2 kg) was exhaustively extracted by maceration with 70 % EtOH (10 L x 3) at room temperature. The combined ethanolic extracts were concentrated under reduced pressure to afford 400 g residue. The residue was successively partitioned with petroleum ether, EtOAc and MeOH. Each extract was evaporated to yield 20 g (Pet. ether), 210 g (EtOAc) and 15 g (MeOH) of residue. The MeOH fraction (15 g) was subjected to vacuum liquid chromatography (VLC) on silica gel (600 g, 45 cm, 15 cm) using 1.0 L each of n-hexane, n-hexane/EtOAc (50:50) and (25:75), EtOAc, EtOAc/MeOH (1:1) and MeOH to give six fractions (F1-F6). Fraction F1(2.1 g) was subjected to VLC on Silica gel(100 g, 45 cm, 5 cm) to give eight subfractions. Subfraction 1(500 mg) was purified by silica gel column (20 g, 45 x 2 cm, n-hexane/ EtOAc, 1:1) to yield compounds 3 (50 mg) and 6 (10 mg). Subfraction 2 (120 mg) was chromatographed (silica gel, 7 g, 25 x 2 cm, n-hexane/EtOAc, 1:1) to give compounds 2 (10 mg) and 5 (40 mg). Subfraction 4 (323 mg) was chromatographed on Sephadex LH-20 with MeOH/CHCl 3 (1:1) to obtain compounds 4 (4 mg) and 7 (50 mg). Subfraction 7 (100 mg) was purified by semipreparative RP-C 18 HPLC with MeOH/H 2 O(75:25 v/v ) using Luna® RP-18(5 µg, 250 x 10 mm) at a flow rate of 5.0 mL/min and detection at 254 nm to give compound 8 (6 mg). Fraction F2 (6 g) was subjected to VLC on silica gel (200 g, 65 x 5 cm) eluting with CHCl 3 /MeOH, isocratic system (100:5) to afford 20 subfractions. Subfraction 17 (150 mg) was purified on Sephadex LH-20, (MeOH/H 2 O, 9:1) to yield compound 9 (120 mg). Subfraction 14 (35 mg) and 19 (50 mg) were subjected to subsequent purification on semipreparative RP-C 18 HPLC eluting with MeOH/H 2 O (60:40 v/v ) isocratic, using Luna® RP-18(5 µg, 250, 10 mm) at a flow rate of 5.0 mL/min and detection at 254 nm to give compounds 10 (9 mg) and 1 (8 mg), respectively. 
Compounds
Estimated IC 50 (µM) HL60 cells K562 cells 7
0.08 ± 0.01 0. 15 ± 0.02 9
0.024 ± 0.001 0.065 ± 0.01 Taxol 0.0005 ± 0.00008 0.0023 ±0.0005
